MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-29-2023
Chembio Diagnostics ROE Ratio 2011-2026 | CEMI
Annual ROE Ratio Chembio Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -130.86 | -98.95 | -91.88 | -56.9 | -23.6 | -48.72 | -77.74 | -13.57 | -5.77 | 2.63 | 6.78 | 49.69 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 49.69 | -130.86 | -40.74 |
Quarterly ROE Ratio Chembio Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -105.67 | -118.96 | -94.59 | -119.71 | -92.63 | -112.57 | -119.22 | -87.45 | -66.18 | -81.92 | -77.72 | -62.74 | -40.72 | -47.66 | -38.86 | -30.79 | -14.09 | -29.37 | -26.89 | -38.32 | -48.72 | -48.33 | -56.32 | -88.32 | -77.74 | -66.51 | -56.54 | -11.68 | -13.57 | -11.27 | -10.17 | -7.15 | -3.25 | 0.3 | 5.22 | 4.77 | 3.93 | 1.82 | -3.84 | -0.42 | 3.24 | 7.05 | 12.96 | 12.3 | 4.23 | 3.81 | 1.56 | -1.14 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 12.96 | -119.71 | -38.54 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Medpace Holdings
MEDP
|
98.27 | $ 462.69 | 1.26 % | $ 13.3 B |  USA |
|
Biodesix
BDSX
|
-205.65 | $ 15.0 | 2.11 % | $ 1.95 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.12 | -0.47 % | $ 4.87 M | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 4.72 | 1.39 % | $ 437 M | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 17.33 | -1.03 % | $ 388 M | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
-41.08 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
-10214.54 | $ 1.41 | 1.08 % | $ 423 M | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 159.3 | 0.77 % | $ 7.9 B | USA |
 |
IQVIA Holdings
IQV
|
20.91 | $ 165.09 | -1.15 % | $ 28.4 B | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
-59.42 | $ 1.21 | -17.12 % | $ 6.59 M | USA |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 263.49 | 1.86 % | $ 26 B |  Schweiz |
 |
Interpace Biosciences
IDXG
|
-302.3 | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 126.26 | 2.0 % | $ 20.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B |  Niderland |
 |
Precipio
PRPO
|
-40.56 | $ 26.8 | -0.48 % | $ 34.8 M | USA |
 |
Personalis
PSNL
|
-40.05 | $ 7.84 | 3.02 % | $ 465 M | USA |
 |
RadNet
RDNT
|
-1.71 | $ 59.64 | -3.4 % | $ 4.48 B | USA |
 |
Celcuity
CELC
|
-96.68 | $ 102.17 | -4.29 % | $ 4.03 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 266.35 | 0.71 % | $ 22.2 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Sotera Health Company
SHC
|
12.86 | $ 13.89 | 0.04 % | $ 3.94 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-449.46 | $ 3.36 | -3.45 % | $ 1.8 M | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 7.98 | -1.48 % | $ 1.02 B | USA |
 |
Soleno Therapeutics
SLNO
|
4.64 | $ 30.65 | -3.37 % | $ 1.56 B | USA |
 |
Natera
NTRA
|
-77.62 | $ 195.28 | -2.4 % | $ 19.2 B | USA |
 |
Senseonics Holdings
SENS
|
-113.21 | $ 6.69 | 1.06 % | $ 279 M | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 17.76 | 1.14 % | $ 946 M | USA |
 |
Neuronetics
STIM
|
-174.27 | $ 1.47 | -8.44 % | $ 96.9 M | USA |
 |
OPKO Health
OPK
|
1.03 | $ 1.14 | -0.87 % | $ 791 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 25.29 | -1.79 % | $ 702 M | USA |
 |
DarioHealth Corp.
DRIO
|
-61.41 | $ 8.0 | 6.67 % | $ 31.9 M | Israel |
 |
DexCom
DXCM
|
30.46 | $ 66.16 | 0.33 % | $ 25.8 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | $ 104.91 | - | $ 19.8 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 46.13 | 3.65 % | $ 2.76 B | USA |